UPDATE: Achillion Has Received US Patent for ACH-3102, Structurally-Related NS5A Inhibitors

By: via Benzinga
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) today announced that the U.S. Patent & Trademark Office has granted Achillion U.S. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.